Drug Development and Clinical Trials of Semaglutide (Ozempic) in Type 2 Diabetes Exam Questions and answers

Drug Development and Clinical Trials of Semaglutide (Ozempic) in Type 2 Diabetes Exam Questions and answers What is the active ingredient in Ozempic? Semaglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist. When was Ozempic approved by the FDA? December 5, 2017. What is the primary use of Ozempic? As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. What was the main purpose of developing semaglutide? To increase stability and decrease unwanted side effects without reducing therapeutic benefit. What is the source of inspiration for the active molecule in Ozempic? Venom of the Gila monster, specifically the hormone exendin-4. How does exendin-4 compare to GLP-1 in terms of activity duration?